In recent years the use of paclitaxel releasing percutaneous transluminal angioplastic (PTA) balloon catheter is spreading in vascular pathology, mainly in stenosis infrainguinal arteries. This device combined the mechanical action of PTA balloon with the antiproliferative effects of paclitaxel. The use of these devices in venous pathology is limited. This devices could improve the treatment of renal dialysis arteriovenous fistula stenosis.

Inclusion Criteria:

• Patient with renal dialysis with arteriovenous fistula (AVF) at least 3 months before.
• Patient diagnosed with AVF stenosis by clinical and radiological criteria
• Sign informed consent

Exclusion Criteria:

• Pregnant or breastfeeding
• Patients with AVF stenosis not could be treated with PTA catheter
• Paclitaxel allergy
• Iodinated contrast allergy
• Local or systemic active infection
• Life expectancy less than 12 moths